Guangdong Kanghua Healthcare Co., Ltd. (3689.HK)
HKD 2.0
(0.0%)
HKD 2.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 121.41 Million CNY | -26.68% |
| 2022 | 165.58 Million CNY | -35.62% |
| 2021 | 257.19 Million CNY | -10.12% |
| 2020 | 286.15 Million CNY | 30.93% |
| 2019 | 218.55 Million CNY | 220.36% |
| 2018 | -181.57 Million CNY | 52.58% |
| 2017 | -382.87 Million CNY | 58.97% |
| 2016 | -933.19 Million CNY | -478.92% |
| 2015 | 246.28 Million CNY | -72.05% |
| 2014 | 881.15 Million CNY | 25.51% |
| 2013 | 702.06 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 140.65 Million CNY | 83.18% |
| 2024 Q1 | 140.65 Million CNY | 15.85% |
| 2023 Q2 | 140.59 Million CNY | 46.3% |
| 2023 FY | 121.41 Million CNY | -26.68% |
| 2023 Q4 | 121.41 Million CNY | 63.63% |
| 2023 Q1 | 96.09 Million CNY | -41.96% |
| 2023 Q3 | 74.19 Million CNY | -47.22% |
| 2022 Q3 | 150.83 Million CNY | -55.69% |
| 2022 Q4 | 165.58 Million CNY | 9.78% |
| 2022 Q2 | 340.43 Million CNY | -11.17% |
| 2022 Q1 | 383.23 Million CNY | 49.01% |
| 2022 FY | 165.58 Million CNY | -35.62% |
| 2021 FY | 257.19 Million CNY | -10.12% |
| 2021 Q2 | 270.07 Million CNY | -9.98% |
| 2021 Q1 | 300.02 Million CNY | 4.85% |
| 2021 Q3 | 267.64 Million CNY | -0.9% |
| 2021 Q4 | 257.19 Million CNY | -3.9% |
| 2020 Q3 | 269.32 Million CNY | -19.36% |
| 2020 Q1 | 446.85 Million CNY | 104.46% |
| 2020 FY | 286.15 Million CNY | 30.93% |
| 2020 Q2 | 333.98 Million CNY | -25.26% |
| 2020 Q4 | 286.15 Million CNY | 6.25% |
| 2019 Q2 | 21.54 Million CNY | -89.82% |
| 2019 Q4 | 218.55 Million CNY | -33.99% |
| 2019 Q3 | 331.11 Million CNY | 1437.19% |
| 2019 FY | 218.55 Million CNY | 220.36% |
| 2019 Q1 | 211.51 Million CNY | 216.49% |
| 2018 Q2 | -294.02 Million CNY | 0.0% |
| 2018 FY | -181.57 Million CNY | 52.58% |
| 2018 Q4 | -181.57 Million CNY | 0.0% |
| 2018 Q3 | -181.57 Million CNY | 38.25% |
| 2018 Q1 | -294.02 Million CNY | 23.2% |
| 2017 Q2 | -450.26 Million CNY | 0.0% |
| 2017 Q3 | -382.87 Million CNY | 14.97% |
| 2017 Q4 | -382.87 Million CNY | 0.0% |
| 2017 FY | -382.87 Million CNY | 58.97% |
| 2017 Q1 | -450.26 Million CNY | 51.75% |
| 2016 Q3 | -933.19 Million CNY | 0.0% |
| 2016 Q1 | 145.35 Million CNY | 0.0% |
| 2016 Q4 | -933.19 Million CNY | 0.0% |
| 2016 FY | -933.19 Million CNY | -478.92% |
| 2015 FY | 246.28 Million CNY | -72.05% |
| 2014 FY | 881.15 Million CNY | 25.51% |
| 2013 FY | 702.06 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aidigong Maternal & Child Health Limited | 767.09 Million HKD | 84.173% |
| UMP Healthcare Holdings Limited | -201.47 Million HKD | 160.261% |
| Human Health Holdings Limited | -458.04 Million HKD | 126.507% |
| EuroEyes International Eye Clinic Limited | -336.12 Million HKD | 136.121% |
| Kato (Hong Kong) Holdings Limited | 336.39 Million HKD | 63.908% |
| Bamboos Health Care Holdings Limited | -18.02 Million HKD | 773.458% |
| Beijing Health (Holdings) Limited | -106.46 Million HKD | 214.036% |
| C-MER Eye Care Holdings Limited | -149.77 Million HKD | 181.064% |
| Town Health International Medical Group Limited | -738.7 Million HKD | 116.436% |
| Medicskin Holdings Limited | -15.06 Million HKD | 906.075% |
| Hang Chi Holdings Limited | 32.96 Million HKD | -268.314% |